Skip to main content
Figure 5 | Journal of Neuroinflammation

Figure 5

From: Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population

Figure 5

MAPC treatment increases CD4 + /CD25 + /FOXP3 + cells after TBI in spleen and blood. (A) Measurement of CD4+/CD25+/FOXP3+ cells was completed in the splenocytes at 24, 48, and 72 hours after CCI injury and CCI injury plus MAPC (nā€‰=ā€‰4/group). There was a significant increase in T regulatory cells as a percentage of CD4+ T helper cells within the spleens of MAPC treated mice at 24 hours (P ā‰¤0.01), with no difference seen at 48 or 72 hours. (B) In peripheral blood, percent T regulatory cells from MAPC treated mice was significantly higher at 48 hours after CCI injury (P ā‰¤0.01). Of note, there is an additional control of sham (uninjured: white bar) for baseline profile of splenocytes. * represents P <0.05 and ** represents P <0.01. CCI, controlled cortical impact; MAPC, multipotent adult progenitor cell; TBI, traumatic brain injury.

Back to article page